在老的重症儿科肺炎中肺炎球菌密度和呼吸道联合检测
Audrey Dubot-Pérès1,2,3, Sue J Lee4,5,6, David A B Dance7,8
1Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), Marseille, France. audrey@tropmedres.ac.
Scientific reports
|May 21, 2025
概括
肺炎中的细菌和病毒共感染是复杂的. 这项研究发现,在老的严重儿童肺炎病例中,肺炎球菌密度与流感有关,但与呼吸道同胞性病毒无关.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 儿科 儿科 儿科
背景情况:
- 肺炎病原发生涉及细菌和病毒病原体之间的复杂相互作用.
- 了解共同检测模式对于管理严重的肺炎至关重要,特别是在资源有限的环境中.
- 有限的数据存在于老的呼吸道病原体共同检测.
研究的目的:
- 在老住院儿童中调查细菌/病毒联合检测和肺炎球菌密度与严重肺炎之间的关联.
- 探索特定病原体组合的作用,如肺炎链球菌和呼吸道同胞病毒 (RSV),在肺炎的严重程度.
主要方法:
- 一项前性研究招募了934名5岁以下的儿童,他们患有急性呼吸道感染 (ARI) 在维也纳的Mahosot医院.
- 用实时PCR检测病原体,分析了上呼吸道抽样.
- 使用统计分析,包括单变量和调整模型,来评估与严重肺炎的关联.
主要成果:
- 最常见的联合检测是肺炎链球菌/流感血球菌 (24%),RSV/S. 肺炎 (12%),以及RSV/海莫菲勒斯流感 (16%).
- 肺炎球菌密度显著更高 (4.52倍) 在感染流感病毒的参与者中.
- 在RSV/S. 肺炎和RSV/Haemophilus influenzae联合检测显示出与严重肺炎的单变异关联,这在调整后的分析中没有持续.
结论:
- 肺炎球菌密度与流感病毒感染有关,但与严重儿童肺炎的RSV感染无关.
- 肺炎中病毒和细菌病原体之间的相互作用可能比简单的协同作用更复杂.
- 这些发现凸显了对肺炎病因学中的病原体相互作用的进一步研究的需要.
相关概念视频
01:30Pneumonia III: Complications and Assessment
137
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
137
01:30Pneumonia I: Introduction
201
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
01:28Pneumonia IV: Management
283
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
283
01:29Pneumonia II: Pathophysiology
197
The pathophysiology of pneumonia involves the following steps:
197